The MAGNITUDE Study is a Phase 3 randomized, placebocontrolled, doubleblind study comparing a combination of an investigational medicine and standard treatment, to a combination of a placebo and standard treatment for men with metastatic prostate cancer.
https://clinicaltrials.gov/ct2/show/NCT03748641?term=NCT03748641&rank=1